lobbying_activities: 1724299

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1724299	24c4b0ba-b479-488e-8c92-d3da81038a38	Q2	CENTER FOR INQUIRY, INC. OFFICE OF PUBLIC POLICY	309470	CENTER FOR INQUIRY, INC. OFFICE OF PUBLIC POLICY	2015	second_quarter	CIV	Throughout April, we lobbied against two resolutions in the House of Representatives, H.J. Res. 43 and 44, that would strike down two new Washington, D.C. laws. The recently approved Reproductive Health Non-Discrimination Amendment Act protects D.C. employees from discrimination in the workplace based on their personal reproductive health care decisions; the Human Rights Amendment Act ensures that LGBT students at religiously affiliated schools and universities in D.C. have equal access to school facilities and services by repealing a discriminatory, explicitly anti-gay exemption in D.C.s Human Rights Act. On April 29, we joined 50 advocacy organizations in writing members of the House to oppose H.J. Res 43 and 44. And on April 30, we also joined 22 religious and secular groups in writing members of the House to oppose the resolutions. During floor debate on H.J. Res. 43, Rep. Bobby Scott introduced this letter into the record. The resolution would pass the House, 228-192.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS)		11500	0	0	2015-08-06T17:29:20.187000-04:00